FIELD: chemistry.
SUBSTANCE: in cyclosporine derivatives of general formula A, B, R1, R2 and X are defined in the description, for use in treating viral hepatitis C.
EFFECT: more effective treatment.
23 cl, 24 ex
Title | Year | Author | Number |
---|---|---|---|
METHODS AND PHARMACEUTICAL COMPOSITIONS FOR TREATMENT AND PREVENTION OF HEPATITIS C INFECTION | 2006 |
|
RU2440822C2 |
QUINOXALINE-CONTAINING COMPOUNDS AS HEPATITIS C VIRUS INHIBITORS | 2008 |
|
RU2493160C2 |
PROMEDICINES OF MODIFIED 2'- AND 3'-NUCLEOSIDES FOR TREATMENT OF FLAVIVIRIDAE INFECTIONS | 2003 |
|
RU2366661C2 |
PYRIDO [2,3-d] PYRIMIDINES, USEFUL AS HCV INHIBITORS AND SYNTHESIS METHODS THEREOF | 2006 |
|
RU2444522C2 |
MODIFIED 2'- AND 3'-NUCLEOSIDES AND USE THEREOF FOR PREPARING DRUG FOR TREATING FLAVIVIRIDAE INFECTIONS | 2011 |
|
RU2483075C2 |
PHOSPHORAMIDATE DERIVATIVES OF NUCLEOSIDES | 2010 |
|
RU2553656C2 |
MODIFIED 2- AND 3-NUCLEOSIDES AND USE THEREOF TO PRODUCE MEDICINAL AGENT, HAVING HEPATITIS C INHIBITING ACTIVITY | 2003 |
|
RU2437892C2 |
MACROCYCLIC HEPATITIS C INHIBITORS | 2006 |
|
RU2436787C2 |
DOSAGE FORMS | 2005 |
|
RU2393863C2 |
SUBSTITUTED INDOLES, ANTIVIRAL ACTIVE COMPONENT, SYNTHESIS AND APPLICATION METHOD | 2010 |
|
RU2436786C1 |
Authors
Dates
2010-09-20—Published
2005-09-30—Filed